Characterization of Campylobacter jejuni isolates from patients with Guillain-Barre syndrome

Journal of the Neurological Sciences

Volumn 153, Issue 1, 1997, Pages 91-99

  Nishimura, Masataka ^a   Nukina, Masafumi ^e   Kuroki, Shigekazu ^d   Obayashi, Hiroshi ^b   Ohta, Mitsuhiro ^a   Jun Ma, Jian ^a   Saida, Takahiko ^a   Uchiyama, Takashi ^c  

^a UTANO NATIONAL HOSPITAL   (Japan)

^b Kyoto Microbiological Institute   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

^e Public Health Research Institute of Kobe City   (Japan)

Author keywords

Campylobacter jejuni; Flagellin; GM1; Guillain Barre syndrome; Miller Fisher syndrome; Restriction fragment length polymorphism (RFLP)

Indexed keywords

GANGLIOSIDE GM1;

ANTIBODY TITER; ARTICLE; BACTERIUM ISOLATION; CAMPYLOBACTER JEJUNI; CLINICAL ARTICLE; DEMYELINATING DISEASE; DNA FINGERPRINTING; GUILLAIN BARRE SYNDROME; HUMAN; NONHUMAN; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SUBCLAVIAN STEAL SYNDROME;

BLOTTING, WESTERN; CAMPYLOBACTER JEJUNI; DNA FINGERPRINTING; DNA, BACTERIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLAGELLIN; GENES, BACTERIAL; HUMANS; IMMUNOGLOBULIN M; LIPOPOLYSACCHARIDES; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYRADICULONEUROPATHY;

EID: 0031458390     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(97)00170-6     Document Type: Article

References (38)

1. Akopyanz N., Bukanov N.O., Westblom T.U., Kresovich S., Berg D.E. DNA diversity among clinical isolates of Helicobacter pylori detected by PCR-based RAPD fingerprinting. Nucleic Acids Res. 20:1992;5137-5142.
2. Asbury A.K., Cornblath D.R. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann. Neurol. 27(Suppl):1990;S21-S24.
3. Aspinall G.O., Fujimoto S., McDonald A.G., Pang H., Kurjanczyk L.A., Penner J.L. Lipopolysaccharides from Campylobacter jejuni associated with Guillain-Barré syndrome patients mimic human gangliosides in structure. Infect. Immun. 62:1994;2122-2125.
4. Boucquey D., Sindic C.J., Lamy M., Delmee M., Tomasi J.P., Laterre E.C. Clinical and serological studies in a series of 45 patients with Guillain-Barré syndrome. J. Neurol. Sci. 104:1991;56-63.
5. Cover T.L., Blaser M.J. The pathobiology of Campylobacter infections in humans. Annu. Rev. Med. 40:1989;269-285.
6. Enders U., Karch H., Toyka K.V., Michels M., Zielasek J., Pette M., Heesemann J., Hartung H.-P. The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barré syndrome and in other neuroimmunological disorders. Ann. Neurol. 34:1993;136-144.
7. Fischer S.H., Nachamkin I. Common and variable domains of the flagellin gene, flaA, in Campylobacter jejuni. Mol. Microbiol. 5:1991;1151-1158.
8. French cooperative group on plasma exchange in Guillain-Barré syndrome 1987. Efficiency of plasma exchange in Guillain-Barré syndrome: role of replacement fluids. Ann. Neurol., 22, pp. 753-761.
9. French cooperative group on plasma exchange in Guillain-Barré syndrome 1992. Plasma exchange in Guillain-Barré syndrome: one-year follow-up. Ann. Neurol., 32, pp. 94-97.
10. Fujimoto S., Yuki N., Itoh T., Amako K. Specific serotype of Campylobacter jejuni associated with Guillain-Barré syndrome. J. Infect. Dis. 165:1992;183.
11. Hitchcock P.J., Brown T.M. Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels. J. Bacteriol. 154:1983;269-277.
12. Kaldor J., Speed B.R. Guillain-Barré syndrome and Campylobacter jejuni: a serological study. Br. Med. J. 288:1984;1867-1870.
13. Kornberg A.J., Penstronk A., Bieser K., Ho T.W., McKhann G.M., Wu H.S., Jiang Z. The clinical correlates of high-titer IgG anti-GM1 antibodies. Ann. Neurol. 35:1994;234-237.
14. Kuroki S., Haruta T., Yoshioka M., Kobayashi Y., Nukina M., Nakanishi H. Guillain-Barré syndrome associated with Campylobacter infection. Pediatr. Infect. Dis. J. 10:1991;149-151.
15. Kuroki S., Saida T., Nukina M., Haruta T., Yoshioka M., Kobayashi Y., Nakanishi H. Campylobacter jejuni strains from patients with Guillain-Barré syndrome belong mostly to Penner serogroup 19 and contain β-N-acetylglucosamine residues. Ann. Neurol. 33:1993;243-247.
16. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophafe T4. Nature. 227:1970;680-685.
17. Lior H., Woodward D.L., Edgar J.A., Laroche L.J., Gill P. Serotyping of Campylobacter jejuni by slide agglutination based on heat-labile antigenic factors. J. Clin. Microbiol. 15:1982;761-768.
18. Nachamkin I., Yang X.H. Human antibody response to Campylobacter jejuni flagellin protein and a synthetic N-terminal flagellin peptides. J. Clin. Microbiol. 27:1989;2195-2198.
19. Nachamkin I., Ung H., Patton C.M. Analysis of HL and O serotypes of Campylobacter strains by the flagellin gene typing system. J. Clin. Microbiol. 34:1996;277-281.
20. Nishimura M., Nukina M., Yuan J.M., Shen B.Q., Ma J.J., Ohta M., Saida T., Uchiyama T. PCR-based restriction fragment length polymorphism (RFLP) analysis and serotyping of Campylobacter jejuni isolates from diarrheic patients in China and Japan. FEMS Microbiol. Lett. 142:1996;133-138.
21. Nuijten, P.J.M., Wassenaar, T.M., Newell, D.G., Van der Zeijst, B.A.M., 1992. Molecular characterization and analysis of Campylobacter jejuni flagellin genes and proteins. In: Nachamkin, I, Blaser, M.J., Tompkins, L.S. (Eds.), Campylobacter jejuni: Current status and future trends-1992, American Society for Microbiology, Washington D.C., pp. 282-296.
22. Patton C.M., Wachsmuth I.K., Evins G.M., Kiehlbauch J.A., Plikaytis B.D., Troup N., Tompkins L., Lior H. Evaluation of 10 methods to distinguish epidemic-associated Campylobacter strains. J. Clin. Microbiol. 29:1991;680-688.
23. Patton, C.M., Wachsmuth, I.K., 1992. Typing schemes: are current methods useful? In: Machamkin, I., Blaser, M.J., Tompkins, L.S. (Eds.), Campylobacter jejuni: Current status and future trends-1992. American Society for Microbiology, Washington D.C., pp.110-128.
24. Penner J.L., Hennessy J.N. Passive hemagglutination technique for serotyping Campylobacter fetus subsp. jejuni on the basis of soluble heat-stable antigens. J. Clin. Microbiol. 12:1980;732-737.
25. Penner J.L., Hennessy J.N., Congi R.V. Serotyping of Campylobacter jejuni and Campylobacter coli on the basis of thermostable antigens. Eur. J. Clin. Microbiol. 2:1983;378-383.
26. Rees J.H., Hughes A.C. Campylobacter jejuni and Guillain-Barré syndrome. Ann. Neurol. 35:1994;248-249.
27. Rees J.H., Soudain S.E., Gregson N.A., Hughes R.A.C. Campylobacter jejuni infection and Guillain-Barré syndrome. N. Engl. J. Med. 333:1995;1374-1379.
28. + currents in isolated rat myelinated nerve fibers. Ann. Neurol. 37:1995;436-442.
29. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA. 76:1979;4350-4354.
30. Visser, L.H., Van der Meche, F.G.A., Van Doorn, P.A., Meulstee, J., Jacobs, B.C., Oomes, P.G., Kleyweg, R.P. and the Dutch Guillain-Barre Study Group, 1995. Guillain-Barré syndrome without sensory loss (acute motor neuropathy). A subgroup with specific clinical, electrodiagnostic and laboratory features. Brain, 118, pp. 841-847.
31. Vriesendorp F.J., Mishu B., Blaser M.J., Koski C.L. Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain-Barré syndrome and controls: correlation and prognosis. Ann. Neurol. 34:1993;130-135.
32. Walsh F.S., Cronin M., Koblar S., Doherty P., Winer J., Leon A., Hughes R.A.C. Association between glycoconjugate antibodies and Campylobacter infection in patients with Guillain-Barré syndrome. J. Neuroimmunol. 34:1991;43-51.
33. Welsh J., McClelland M. Fingerprinting genomes using PCR with arbitrary primers. Nuc. Acids Res. 18:1990;7213-7218.
34. Williams J.G.K., Kubelik A.R., Livak K.J., Rafalski J.A., Tingey S.V. DNA polymorphisms amplified by arbitrary primers are useful as genetic markers. Nuc. Acids Res. 18:1990;6531-6535.
35. Winer J.B., Hughes R.A.C., Anderson M.J., Lones D.M., Kangro H., Watkins R.P.F. A prospective study of acute idiopathic neuropathy II. Antecedent events. J. Neurol. Neurosurg. Psychiatry. 51:1988;613-618.
36. Yaoita Y., Honjo T. Detection of immunoglobulin heavy chain genes accompanies the class switch rearrangement. Biomed. Res. 1:1980;164-175.
37. Yuki N., Yoshino H., Sato S., Miyatake T. Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis. Neurology. 40:1990;1900-1902.
38. Yuki N., Taki T., Inagaki F., Kasama T., Takahashi M., Saito K., Hanada S., Miyatake T. A bacterium lipopolysaccharide that elicits Guillain-Garré syndrome has a GM1 ganglioside-like structure. J. Exp. Med. 178:1993;1771-1775.